Abstract
An adolescent male with chronic schizophrenic disorder, paranoid type, was treated with molindone. He developed hepatotoxicity in the early treatment phase as evidenced by flu-like symptoms and laboratory abnormalities of liver functions. These symptoms and his hepatic functions improved on discontinuing molindone. Similar liver function trends were seen on reintroduction and subsequent withdrawal of the drug. Hepatic hypersensitivity has not been reported previously with the use of this drug. It is suggested that clinicians should be aware of this association and should assess hepatic functions in patients who develop a prodromal flu-like syndrome with this drug, especially in the early treatment phase.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 744-746 |
| Number of pages | 3 |
| Journal | Drug Intelligence and Clinical Pharmacy |
| Volume | 19 |
| Issue number | 10 |
| DOIs | |
| State | Published - Jan 1 1985 |
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Molindone and hepatotoxicity'. Together they form a unique fingerprint.
Cite this
Bhatia, S. C., Banta, L. E., & Ehrlich, D. W. (1985). Molindone and hepatotoxicity. Drug Intelligence and Clinical Pharmacy, 19(10), 744-746. https://doi.org/10.1177/106002808501901011